Skip to content Skip to footer

An Open Label, Multicentre, Phase One Study Incorporating Early Application of CAR T cells for Primary Refractory Aggressive Lymphoma (2019-2027)

Experts

Professor Maher Gandhi

Honorary Professor
Mater Research Institute-UQ
Faculty of Health, Medicine and Behavioural Sciences
Maher Gandhi
Maher Gandhi

Associate Professor Colm Keane

Amplify Principal Research Fellow
Frazer Institute
Faculty of Health, Medicine and Behavioural Sciences
Colm Keane